Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
5,401
archived clinical trials in
Alzheimer Disease

A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Richard H. Weisler, MD, PA
372
mi
from 43215
Raleigh, NC
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Richard H. Weisler, MD, PA
372
mi
from 43215
Raleigh, NC
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Tulsa Clinical Research
750
mi
from 43215
Tulsa, OK
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Tulsa Clinical Research
750
mi
from 43215
Tulsa, OK
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Abington Neurological Associates
418
mi
from 43215
Willow Grove, PA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Abington Neurological Associates
418
mi
from 43215
Willow Grove, PA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Rhode Island Mood & Memory Research Institute
621
mi
from 43215
East Providence, RI
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neurology Clinic, PC
497
mi
from 43215
Cordova, TN
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neurology Clinic, PC
497
mi
from 43215
Cordova, TN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Senior Adults Specialty Research
1065
mi
from 43215
Austin, TX
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Senior Adults Specialty Research
1065
mi
from 43215
Austin, TX
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
University of Utah Center for Alzheimer's Care, Imaging and Research
1509
mi
from 43215
Salt Lake City, UT
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
University of Utah Center for Alzheimer's Care, Imaging and Research
1509
mi
from 43215
Salt Lake City, UT
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Instituto Neurologia Bs As
5382
mi
from 43215
Ciudad Autonoma de Bs As,
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Instituto Neurologia Bs As
5382
mi
from 43215
Ciudad Autonoma de Bs As,
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center for Orange County
1959
mi
from 43215
Orange, CA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center for Orange County
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Radiant Research, Inc.
1153
mi
from 43215
Denver, CO
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Neuropsychiatric Research Center of Southwest Florida
922
mi
from 43215
Fort Myers, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
978
mi
from 43215
Hollywood, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Collier Neurologic Specialists
957
mi
from 43215
Naples, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Collier Neurologic Specialists
957
mi
from 43215
Naples, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Progressive Medical Research
758
mi
from 43215
Port Orange, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Progressive Medical Research
758
mi
from 43215
Port Orange, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Indiana University
167
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Northeastern Pennsylvania Memory
386
mi
from 43215
Plains, PA
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Northeastern Pennsylvania Memory
386
mi
from 43215
Plains, PA
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Territory Neurology & Research Institute
1638
mi
from 43215
Tucson, AZ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Territory Neurology & Research Institute
1638
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Alzheimer's Research Corporation
457
mi
from 43215
Manchester, NJ
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Alzheimer's Research Corporation
457
mi
from 43215
Manchester, NJ
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Bioclinica Research
795
mi
from 43215
Orlando, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Bioclinica Research
795
mi
from 43215
Orlando, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Bioclinica The Villages
764
mi
from 43215
The Villages, FL
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Bioclinica The Villages
764
mi
from 43215
The Villages, FL
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research
208
mi
from 43215
Kalamazoo, MI
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Western Michigan University Homer Stryker M.D. School of Medicine Center for Clinical Research
208
mi
from 43215
Kalamazoo, MI
Click here to add this to my saved trials
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated:  12/31/1969
Millennium Psychiatric Associates, LLC
394
mi
from 43215
Saint Louis, MO
A Study of Gantenerumab in Participants With Mild Alzheimer Disease
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients With Mild Alzheimer's Disease; Part II: Open-Label Extension For Participating Patients
Status: Enrolling
Updated: 12/31/1969
Millennium Psychiatric Associates, LLC
394
mi
from 43215
Saint Louis, MO
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Alzheimer'S Institute
1660
mi
from 43215
Phoenix, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Banner Sun Health Research Institute
1669
mi
from 43215
Sun City, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Arizona Health Sciences Center
1641
mi
from 43215
Tucson, AZ
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Arizona Health Sciences Center
1641
mi
from 43215
Tucson, AZ
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neurology Center of North Orange County
1959
mi
from 43215
Fullerton, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neurology Center of North Orange County
1959
mi
from 43215
Fullerton, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
UCSD Comprehensive Alzheimer's Program
1954
mi
from 43215
La Jolla, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
UCSD Comprehensive Alzheimer's Program
1954
mi
from 43215
La Jolla, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Uc Irvine Medical Center
1959
mi
from 43215
Orange, CA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Uc Irvine Medical Center
1959
mi
from 43215
Orange, CA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Geriatric and Adult Psychiatry, LCC
538
mi
from 43215
Hamden, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Geriatric and Adult Psychiatry, LCC
538
mi
from 43215
Hamden, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Yale University, Alzheimer's Disease Research Unit
537
mi
from 43215
New Haven, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Yale University, Alzheimer's Disease Research Unit
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Research Center for Clinical Studies, Inc.
510
mi
from 43215
Norwalk, CT
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Research Center for Clinical Studies, Inc.
510
mi
from 43215
Norwalk, CT
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Infinity Clinical Research, LLC
978
mi
from 43215
Hollywood, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Infinity Clinical Research, LLC
978
mi
from 43215
Hollywood, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Miami Miller School of Medicine
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Scientific Clinical Research
985
mi
from 43215
North Miami, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Scientific Clinical Research
985
mi
from 43215
North Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Renstar Medical Research
746
mi
from 43215
Ocala, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Meridien Research
830
mi
from 43215
Tampa, FL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Meridien Research
830
mi
from 43215
Tampa, FL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Neuro Trials Research, Inc
436
mi
from 43215
Atlanta, GA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Neuro Trials Research, Inc
436
mi
from 43215
Atlanta, GA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Rush University Medical Center
277
mi
from 43215
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
SIU School of Medicine
351
mi
from 43215
Springfield, IL
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
SIU School of Medicine
351
mi
from 43215
Springfield, IL
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Indiana Medical Research
195
mi
from 43215
ELkhart, IN
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Indiana Medical Research
195
mi
from 43215
ELkhart, IN
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Indiana University Health Partners, Adult Neurology Clinic
166
mi
from 43215
Indianapolis, IN
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Indiana University Health Partners, Adult Neurology Clinic
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Kansas/Clinical and Translational Science Unit
784
mi
from 43215
Fairway, KA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Kansas/Clinical and Translational Science Unit
784
mi
from 43215
Fairway, KA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Kentucky Sanders-Brown Center on Aging Clinic
154
mi
from 43215
Lexington, KY
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Kentucky Sanders-Brown Center on Aging Clinic
154
mi
from 43215
Lexington, KY
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
803
mi
from 43215
Baton Rouge, LA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
803
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Acadia Hospital
798
mi
from 43215
Bangor, ME
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Acadia Hospital
798
mi
from 43215
Bangor, ME
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Boston University Alzheimer's Disease Center
643
mi
from 43215
Boston, MA
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Boston University Alzheimer's Disease Center
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
University of Michigan Health System/ Michigan Clinical Research Unit
164
mi
from 43215
Ann Arbor, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
University of Michigan Health System/ Michigan Clinical Research Unit
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Michigan State University
205
mi
from 43215
East Lansing, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Michigan State University
205
mi
from 43215
East Lansing, MI
Click here to add this to my saved trials
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated:  12/31/1969
Bronson Neurobehvioral Health
215
mi
from 43215
Paw Paw, MI
Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease (US202)
A Phase 2 Multi-center, Randomized, Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of T-817MA in Patients With Mild to Moderate Alzheimer's Disease
Status: Enrolling
Updated: 12/31/1969
Bronson Neurobehvioral Health
215
mi
from 43215
Paw Paw, MI
Click here to add this to my saved trials